IPHARMA continue to hold a series of webinars in order to provide information to the vast media audience on various aspects of clinical trials conduct.
At the annual conference "Achievements and Prospects of Clinical Endocrinology" the results of clinical trial of the first domestic DPP-4 inhibitor Gosogliptin has been presented.
Webinar "Clinical trials history. The clinical trial participants and the effective distribution of responsibilities"
When a regular customer walks into a pharmacy and buys medicinal drugs, he can’t even think of a great piece of work that stands behind a new drug development. There are thousands of people, many years of research, huge investments. And all of this in order to make a new drug as safe and effective as possible.
The report of IPHARMA Medical Director
Julia Trachtenberg at the Adam Smith Forums "Medical Department in Russia" and "Clinical Trials in Russia".
The efficacy and safety of new HIV reverse transcriptase inhibitor (VM1500, Elpivirin) as part of antiretroviral therapy
IPHARMA article "The efficacy and safety of a new national non-nucleoside inhibitor of HIV reverse transcriptase (VM1500, Elpivirin) as part of antiretroviral therapy " In the journal "Epidemiology and Infectious Diseases" №5 / 2015.